CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 59 enrolled
Drug / intervention
Sleep Wellness Device (BeCurie)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05952297
NCT05952297Phase 2Completed
CompareCT.gov

A Novel Wearable Device to Improve Sleep Quality

University of Utah·interventional·Posted Jul 19, 2023·Updated Mar 28, 2025

In Brief

A Phase 2 clinical trial evaluating Sleep Wellness Device (BeCurie) for Insomnia. Completed, enrolled 59 participants across 1 site.

Detailed Summary

The purpose of the study is to help determine if a wearable sleep wellness device improves sleep among adults with insomnia. This study will enroll a total of 60 participants for this remotly conducted study and randomize 1:1 for treatment and control. Aim 1 of the study is to test the effects of the sleep wellness device compared to a placebo device on sleep after 28 days of use. Aim 2 of the study is to test the longer term effects of the sleep wellness device at 3 month follow-up.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsomnia
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
202420252026
First PostedJul 19, 2023
Enrollment StartSep 1, 2023
Primary CompletionMay 1, 2024
Study CompletionJul 17, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.0 years ago

Interventions

Sleep Wellness Device (BeCurie)device

This device emits micro electromagnetic stimulation